Table of Contents






Indicators 2a
 1) Number of misoprostol tablets distributed
2) Coverage of  misoprostol in pharmacies 
3) Number of pharmacy personnel trained in misoprostol for PAC 
4) Percentage of pharmacy personnel who give correct counseling for misoprostol for PAC
5) Number of medical abortion (MA) product distributed
6) Coverage of  medical abortion (MA) product in pharmacies
7) Number of pharmacy personnel trained in MA dispensing/counseling practices
8) Percentage of pharmacy personnel who give correct counseling to clients for MA

 

Indicator

2a-1

 

  
Number of misoprostol tablets distributed 
 
Workplan:   X misoprostol tablets distributed by Dec. 2018
Indicator Type
 Mandatory for country platforms marketing misoprostol
Where Reported
 Workplan, Tracker
Numerator
 # of tablets sold and distributed for free
Denominator
 N/A
Purpose
 To measure misoprostol availability
Data Source
 MIS
Data Collection Frequency
 Monthly
Notes:
 Guidance:
  • Free distribution must be less than 15% of total distribution (sales + free), from the point of registration and importation for PAC.
  • In certain circumstances (e.g., where necessary to conduct pilot studies with free commodities in order to facilitate registration for PAC), more than 15% of total distribution may be permitted with approval from WHP Project Director.
  • Only include distribution of misoprostol tablets purchased with WHP funds.
Tracker:
  • Record the number of misoprostol tablets sold and distributed for free by channel (pharmacies, network providers, non-network providers, MoH, NGOs/other) on separate rows
Workplan:Report the number of misoprostol tablets distributed (free plus sold) under both “Total Project” and “Period Achievement” at appropriate activity line on workplan


































 

Indicator

2a-2

  
Coverage of misoprostol in pharmacies
 
Workplan:    Increase, from X to Y, percentage of areas meeting coverage benchmark for misoprostol by Dec. 2018
Indicator Type
 Mandatory for all countries distributing misoprostol
Where Reported
 Workplan
Numerator
 # of areas (lots) meeting coverage benchmark
Denominator
 total # of areas surveyed
Purpose
 To measure misoprostol availability
Data Source
 MAP or pharmacy survey
Data Collection Frequency
 Twice during project period
Notes:
 Method of Measurement:
  • Coverage benchmark needs to be determined prior to the survey and defined in the workplan.
  • Coverage benchmark could be defined as at least one pharmacy stocking misoprostol in a reasonably sized area (such as a village or district).
  • Coverage benchmark could be set higher to improve access to misoprostol.
  • MAP survey should be stratified to ensure national and regional coverage estimates.
  • Pharmacy survey is only acceptable if the full sampling frame of pharmacies is known.



























 

Indicator

2a-3

  
Number of pharmacy personnel trained in misoprostol for PAC
 
(Required activity in workplan)
Indicator Type
 Mandatory Activity Level
(If not legally permitted, propose another indicator)
Where Reported
 Workplan at activity level, Tracker
Numerator
 # of pharmacy personnel trained
Denominator
 N/A
Purpose
 To measure misoprostol availability
Data Source
 MIS or pharmacy survey
Data Collection Frequency
 As available, at least every 6 months
Notes:
 Definition:
  • Pharmacy personnel may include pharmacists, pharmacy assistants, counter agents or any personnel who dispenses medicines to clients.
  • Training refers to initial training provided by PSI in an organized classroom setting (e.g., seminars, workshops, etc). Does not include refresher training.
Tracker:
  • Record the number of pharmacy personnel who were trained in misoprostol for PAC during that month.  (Do not report the cumulative sum of pharmacy personnel trained over the life of the project.)
Workplan:
  • Report number of pharmacy personnel trained for both “Total Project” and “Period Achievement” at appropriate activity line on workplan
































 

Indicator

2a-4

  
Percentage of pharmacy personnel who give correct counseling for misoprostol for PAC
 
(Not in workplan, internal only – not reported to donor)
Indicator Type
 Mandatory
(If not legally permitted, propose another indicator)
Where Reported
 Tracker only
Numerator
 # of pharmacy personnel who give correct counseling instructions for misoprostol for PAC
Denominator
 total # of pharmacy personnel surveyed
Purpose
 To measure provider knowledge of misoprostol for PAC
Data Source
 Mystery client survey OR  survey of pharmacy personnel
Data Collection Frequency
 Twice during project period
Notes:
 Definition:
  • Correct counseling includes: dosage, route of administration, frequency of administration, side effects, and warning signs.
  • Pharmacy personnel may include pharmacists, pharmacy assistants, counter agents or any personnel who dispenses medicines to clients.




























 

Indicator

2a-5

  
Number of medical abortion product distributed 
 
Workplan:X medical abortion products distributed by Dec. 2018
Indicator Type
 Mandatory for country platforms marketing medical abortion (MA) product
Where Reported
 Workplan, Tracker
Numerator
 # of medical abortion product  sold and distributed for free
Denominator
 N/A
Purpose
 To measure MA availability
Data Source
 MIS
Data Collection Frequency
 Monthly
Notes:
 Guidance:
  • Free distribution must be less than 25% of total distribution (sales + free).
  • Only include MA purchased with WHP funds.
Tracker:
  • Record the number of medical abortion product distributed for free and sold by channel (pharmacies, network providers, non-network providers, MoH, NGOs/other) on separate rows
Workplan:Report the number of medical abortion product distributed (free plus sold) under both “Total Project” and “Period Achievement” at appropriate activity line on workplan




























 

Indicator

2a-6

  
Coverage of medical abortion (MA) product in pharmacies
 
Workplan:   Increase, from X to Y, percentage of areas meeting coverage benchmark for medical abortion product by Dec. 2018
Indicator Type
 Mandatory for all countries distributing  medical abortion (MA) product
Where Reported
 Workplan
Numerator
 # of areas (lots) meeting coverage benchmark
Denominator
 total # of areas surveyed
Purpose
 To measure MA availability
Data Source
 MAP or pharmacy survey
Data Collection Frequency
 Twice during project period
Notes:
 Method of Measurement:
  • Coverage benchmark needs to be determined prior to the survey and defined in the workplan.
  • Coverage benchmark could be defined as at least one pharmacy stocking MA in a reasonably sized area (such as a village or district).
  • Coverage benchmark could be set higher to improve access to MA.
  • MAP survey should be stratified to ensure national and regional coverage estimates.
  • Pharmacy survey is only acceptable if the full sampling frame of pharmacies is known.



























 

Indicator

2a-7

  
Number of pharmacy personnel trained in MA dispensing / counseling practices
 
(Required activity in workplan)
Indicator Type
 Mandatory Activity Level
(If not legally permitted, propose another indicator)
Where Reported
 Workplan at activity level, Tracker
Numerator
 # of pharmacy personnel trained in MA dispensing/counseling practices
Denominator
 N/A
Purpose
 To measure provider knowledge of MA
Data Source
 MIS or pharmacy survey
Data Collection Frequency
 At least every 6 months
Notes:
 Definition:
  • Pharmacy personnel may include pharmacist, pharmacy assistants, counter agents or any personnel that dispenses medicines to clients.
  • Training refers to initial training provided by PSI.  Does not include refresher training.
Tracker:
  • Report the number of pharmacy personnel who were trained in MA dispensing/counseling during that month. (Do not report the cumulative sum of pharmacy personnel trained over the life of the project.)
Workplan: 
  • Report number of pharmacy personnel trained for both “Total Project” and “Period Achievement” at appropriate activity line on workplan
 































 

Indicator

2a-8

  
Percentage of pharmacy personnel who give correct counseling to clients for MA
 
Workplan:  Increase, from X to Y, the percentage of pharmacy personnel who give correct counseling instructions for MA, by Dec. 2018
Indicator Type
 Mandatory
(If not legally permitted, propose another indicator)
Where Reported
 Workplan, Tracker
Numerator
 # of pharmacy personnel who give correct counseling instructions for MA
Denominator
 total # of pharmacy personnel surveyed
Purpose
 To measure provider knowledge of MA
Data Source
 Mystery client survey OR  survey of pharmacy personnel
Data Collection Frequency
 Twice during project period
Notes:
 Definition:
  • Correct counseling includes: dosage, route of administration, frequency of administration, side effects, and warning signs.
  • Pharmacy personnel may include pharmacists, pharmacy assistants, counter agents or any personnel who dispenses medicines to clients.
  • See standard questionnaire on Pharmacist knowledge and use of misoprostol, and mystery client study guide.
  • http://kix.psi.org/pages/viewpage.action?pageId=81433547